You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

List of Excipients in API fenofibric acid


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing fenofibric acid

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 FERRIC OXIDE RED
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 FERRIC OXIDE YELLOW
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 FERROSOFERRIC OXIDE
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 GELATIN
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 HYDROXYPROPYL CELLULOSE
AbbVie Inc TRILIPIX fenofibric acid 0074-9642 HYPROMELLOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing fenofibric acid

Company Ingredient NDC Excipient
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 ACETYLTRIBUTYL CITRATE
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 ALCOHOL
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 AMMONIA
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 BUTYL ALCOHOL
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 CELLULOSE, MICROCRYSTALLINE
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324 ETHYLCELLULOSES
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for fenofibric acid

Excipient focus: ACETYLTRIBUTYL CITRATE

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBUTYL SEBACATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE PHTHALATE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

fenofibric acid drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC fenofibric acid 0115-1324
Par Pharmaceutical Inc fenofibric acid 10370-209
AR Scientific Inc fenofibric acid 13310-101
TWi Pharmaceuticals Inc fenofibric acid 24979-109
Macleods Pharmaceuticals Limited fenofibric acid 33342-294
Laurus Labs Limited fenofibric acid 42385-944
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group